earnings
confidence high
sentiment negative
materiality 0.85
Outset Medical Q2 revenue $27.4M (-24% YoY); FY2024 guidance cut to ~$110M from $145-153M
Outset Medical, Inc.
2024-Q2 EPS reported
-$1.45
revenue$55,556,000
- Product revenue fell to $19.2M; service revenue rose 21.5% to $8.2M.
- GAAP net loss $(0.66)/share; non-GAAP net loss $(0.47)/share.
- Total gross margin improved to 35.7% from 21.4% YoY; non-GAAP gross margin 37.3%.
- FY2024 revenue guidance revised to ~$110M (prior $145-153M); non-GAAP gross margin now low-to-mid 30%.
- New console placements below expectations; company taking steps to improve execution.